Neural Stem Cell–Mediated Enzyme/Prodrug Therapy for Glioma: Preclinical Studies

Author:

Aboody Karen S.12,Najbauer Joseph1,Metz Marianne Z.1,D’Apuzzo Massimo3,Gutova Margarita1,Annala Alexander J.1,Synold Timothy W.4,Couture Larry A.5,Blanchard Suzette6,Moats Rex A.7,Garcia Elizabeth1,Aramburo Soraya1,Valenzuela Valerie V.1,Frank Richard T.1,Barish Michael E.1,Brown Christine E.8,Kim Seung U.9,Badie Behnam2,Portnow Jana10

Affiliation:

1. Department of Neurosciences, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA 91010, USA.

2. Division of Neurosurgery, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA 91010, USA.

3. Department of Pathology, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA 91010, USA.

4. Department of Clinical and Molecular Pharmacology, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA 91010, USA.

5. Center for Applied Technology Development, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA 91010, USA.

6. Division of Biostatistics, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA 91010, USA.

7. Department of Radiology, Children’s Hospital of Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA 90027, USA.

8. Department of Cancer Immunotherapeutics and Tumor Immunology, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA 91010, USA.

9. Division of Neurology, Department of Medicine, UBC Hospital, University of British Columbia, Vancouver, British Columbia V6T2B5, Canada.

10. Department of Medical Oncology and Experimental Therapeutics, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA 91010, USA.

Abstract

Neural stem cells home to gliomas in mice where they convert a prodrug to 5-fluorouracil, leading to tumor regression.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3